← Evidence map

TrialPloS one2013

Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinib.

Matthias Scheffler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 23308140